to.varga
TL2 · Bursa
Contributes reviews on supplier material. Based in Bursa.
Joined 14 December 2024 · last posted 4d
91 posts, newest first. Showing up to 150.
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #106 · Start Here › Welcome · 24 Jul 2026 · 19 likes Likes here mean "this helped", not "I agree". People like posts that argue against them, and that is deliberate.
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #26 · Evidence › Preprints · 16 Jul 2026 · 0 likes Picking up post #24: that is the part I would want checked first. A preprint that has been up for two years without appearing in a journal is telling you something, and…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #86 · Practice › Interactions · 16 Jul 2026 · 24 likes Renal or hepatic impairment changes the calculus for a lot of combinations and is the context most often missing from an interaction question here.
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #65 · Practice › Dosing & titration · 15 Jul 2026 · 0 likes If you are stepping up mainly because the schedule says so rather than because the current dose has stopped doing what you wanted, that is worth noticing before rather…
-
Research-use-only status: what it means legally and practically Replied, post #75 · Compounds › Other compounds · 14 Jul 2026 · 8 likes Adding the measurement that post #72 says would settle it. Summarising the research-use-only status thread so far, since it is long and the answer is buried: the first…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #37 · Start Here › Welcome · 13 Jul 2026 · 0 likes The tag pages are usually a better entry point than the categories for a first read. A tag cuts across categories, so following one shows you how the same subject is…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #4 · Access › Insurance & coverage · 6 Jul 2026 · 17 likes Tier placement and step therapy: some formularies place a medication on a higher tier or require you to fail cheaper alternatives before approving the one you want.…
-
What steady state means for the decision to escalate Replied, post #22 · Practice › Dosing & titration · 1 Jul 2026 · 5 likes Reporting rather than recommending, on steady state. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #11 · Practice › Side effects · 27 Jun 2026 · 0 likes Since Taste changes and food aversion keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #46 · Start Here › Welcome · 27 Jun 2026 · 1 like Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
Journal club: what we got wrong in an earlier session Replied, post #33 · Evidence › Journal club · 27 Jun 2026 · 28 likes That is a cleaner way of putting what I was circling around.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #100 · Practice › Reconstitution · 27 Jun 2026 · 12 likes Post #96 and I disagree about the size of the effect, not about the direction. A vial that will not fully dissolve: check in order: is the diluent genuinely room…
-
Tracking a shortage from primary sources rather than rumour Replied, post #65 · Access › Shortages · 23 Jun 2026 · 7 likes Switching presentation or strength during a shortage is a prescribing decision rather than a substitution anybody should improvise.
-
Asking a follow-up: new topic or new reply? Replied, post #4 · marked as the solution · Start Here › How to Ask · 8 Jun 2026 · 24 likes Coming back to post #2, because the follow-up matters more than the original answer. I would be cautious about generalising from the asking a follow-up example above.…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #53 · Safety › Contraindications · 28 May 2026 · 4 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
-
Prescription requirements and telehealth models — a second dataset Replied, post #35 · Sourcing › Regulatory · 19 May 2026 · 0 likes Thank you — that answers what I came here to find out.
-
The headache that turns out to be dehydration — the long version Replied, post #36 · Nutrition & Training › Hydration & electrolytes · 16 May 2026 · 16 likes Adding a data point of agreement rather than a data point.
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #120 · Devices › Syringes & needles · 14 May 2026 · 1 like Dead volume: residual liquid in the hub and needle after withdrawal. Typical residual is 0.01 to 0.02 mL for an insulin syringe with a fixed needle. Accounting for it…
-
Why we ask for units every single time, with three examples of what goes wrong — what… Replied, post #6 · Start Here › How to Ask · 10 May 2026 · 0 likes Narrowing post #3, because the general version has more than one answer. Say what you have already ruled out. "It is not the diluent because I tried a second vial from…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #77 · Clinical › Bloodwork · 8 Apr 2026 · 7 likes Post #74 is right about the mechanism and I think understates the practical bit. The failure mode on reference intervals is boring rather than dramatic. It is almost…
-
Reading U-100 graduations, with a conversion table Replied, post #20 · Devices › Syringes & needles · 6 Apr 2026 · 0 likes Reading U-100 graduations has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #105 · Clinical › Bloodwork · 19 Mar 2026 · 17 likes Where the panel discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with…
-
Publication bias detection and its low power — does this still hold? Replied, post #17 · Evidence › Meta-analyses · 13 Mar 2026 · 1 like Adding the measurement that post #16 says would settle it. The reason Publication bias detection keeps being re-asked is that the answer is conditional and people quote…
-
Grapefruit: why this class is not the class that cares Replied, post #32 · Practice › Interactions · 12 Mar 2026 · 0 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
-
Choosing which test to pay for, given a fixed budget Replied, post #17 · Sourcing › Independent verification · 8 Mar 2026 · 14 likes Post #15 put the caveat in the right place and I want to underline it. The record shows what was measured. Everything beyond that is inference and this site tries to…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #134 · Compounds › Semaglutide · 3 Mar 2026 · 1 like Semaglutide's structure is a modified backbone with a C18 diacid attached through a spacer. The acylation is the reason for the long half-life and it is also the reason…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #57 · Meta › Site feedback · 29 Jan 2026 · 5 likes Confirming post #54 from a second method, which matters more than confirming it from a second person. Community norms: if you think a norm has drifted or is not being…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #123 · Compounds › Oral incretins · 1 Jan 2026 · 0 likes Oral semaglutide's bioavailability is low and variable, which is why the dose numbers are an order of magnitude different from the injectable. That is a formulation…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #91 · Analytics › COA interpretation · 16 Dec 2025 · 0 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #41 · Sourcing › Regulatory · 16 Dec 2025 · 27 likes Everything in post #39 holds. The case it does not cover is the one I have. A compound in a compounding pathway in one country and unavailable in another is a common…
-
Publishing an inconvenient result: a case study — the long version Replied, post #72 · Sourcing › Independent verification · 16 Dec 2025 · 0 likes Genuine question rather than a rhetorical one: has anyone here actually observed Publishing an inconvenient result, as opposed to read about it? The thread is long and…
-
Why "add 2 mL" is not an instruction Replied, post #15 · Practice › Reconstitution · 7 Dec 2025 · 9 likes Post #12 is right about the mechanism and I think understates the practical bit. Preservative effectiveness is tested against a defined microbial challenge under…
-
History of disordered eating and why it changes the conversation Replied, post #23 · Clinical › Special populations · 19 Nov 2025 · 16 likes Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration. That…
-
[2026 update] What steady state means for the decision to escalate Replied, post #11 · Practice › Dosing & titration · 5 Nov 2025 · 0 likes What I can speak to on steady state is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #27 · Documentation › Doc review · 4 Nov 2025 · 18 likes Noted, and thank you for writing it out rather than summarising it.
-
How to read a forest plot, properly, from scratch Replied, post #48 · Evidence › Trials · 30 Oct 2025 · 17 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #107 · Practice › Storage & stability · 28 Oct 2025 · 16 likes Confirming post #104 from a second method, which matters more than confirming it from a second person. Visible particulate is a strong signal in the other direction: it…
-
Reconciling a supplier certificate with an independent result Replied, post #12 · Sourcing › Vendor reports · 23 Oct 2025 · 0 likes Post #10 describes the usual case. This is about the unusual one. Structured report format: compound, lot, independent testing service, method as reported, result, and…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #36 · Compounds › Tirzepatide · 20 Oct 2025 · 12 likes Marking my place. If it changes for me I will come back and say so.
-
A parcel stationary at a customs facility for nine days Started this topic · Sourcing › Logistics · 20 Oct 2025 · 6 likes On the subject in the title: A parcel stationary at a customs facility for nine days Working notes rather than a conclusion. A logistics question, since the answers…
-
Payment method and the leverage it gives you, ranked Replied, post #23 · Sourcing › Payments · 17 Sep 2025 · 2 likes Picking up post #22: that is the part I would want checked first. Recording the time from payment to dispatch is worth doing, because it is the part of the process most…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #117 · Evidence › Study critique · 16 Sep 2025 · 8 likes The pre-specified endpoint being a weaker proxy than you would like is a real criticism. It is a smaller one than saying the result was chosen after the fact. If the…
-
MHRA statements, read directly Replied, post #4 · Regional › UK & Ireland · 16 Sep 2025 · 0 likes The most useful contribution is a link to the current official page with the date you accessed it. That survives; a paraphrase does not. I would rather be precise about…
-
Thyroid function tests during substantial weight change Replied, post #59 · Clinical › Bloodwork · 12 Sep 2025 · 13 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #55 · Practice › Reconstitution · 6 Sep 2025 · 0 likes The number people quote for decimal-point error is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #117 · Practice › Reconstitution · 1 Sep 2025 · 0 likes On post #115 — agreed on the reasoning, with one qualification. The most useful reply I ever got about 10 mg vial reconstituted three was a request to state my units.…
-
Confounding by indication, explained with a concrete example Started this topic · Evidence › Study critique · 29 Aug 2025 · 0 likes On the subject in the title: Confounding by indication, explained with a concrete example Working notes rather than a conclusion. Comparing SURMOUNT-1 ( N Engl J Med ,…
-
Follow-up: Why appetite effects are mostly central Replied, post #28 · Pharmacology › Receptor biology · 29 Aug 2025 · 28 likes Everything in post #26 holds. The case it does not cover is the one I have. The useful distinction on appetite effects is between what was measured and what was…
-
Coming back to: Lurking for two months before posting: was that the right call? Replied, post #32 · Start Here › Welcome · 28 Aug 2025 · 8 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #88 · Compounds › Oral incretins · 24 Aug 2025 · 10 likes Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #46 · Practice › Side effects · 22 Aug 2025 · 21 likes Picking up post #44: that is the part I would want checked first. Fatigue is commonly described and hard to attribute. Substantial energy restriction produces it on its…
-
MALDI versus ESI for a quick identity check Replied, post #2 · Analytics › Mass spectrometry · 21 Aug 2025 · 6 likes No notes. Posting so the count is not one.
-
The nausea timeline across the first four weeks, with a tabulated log Started this topic · Practice › Side effects · 15 Aug 2025 · 40 likes The nausea timeline across the first four weeks, with a tabulated log — setting out what I have, and where I think it stops being reliable. Collecting what is known…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #59 · Compounds › Secretagogues & GH axis · 13 Aug 2025 · 31 likes Post #56 is right about the mechanism and I think understates the practical bit. Storage: these are lyophilised short peptides and are generally reasonably stable dry…
-
Realistic expectations for strength while losing weight quickly Replied, post #13 · Nutrition & Training › Resistance training · 11 Aug 2025 · 3 likes If you are new and reading this thread for the answer to realistic expectations for strength: the answer is conditional, the conditions are in the third reply, and the…
-
Publishing an inconvenient result: a case study Replied, post #62 · Sourcing › Independent verification · 7 Aug 2025 · 9 likes Marking my uncertainty on publishing an inconvenient result explicitly. I am confident about the direction, much less confident about the size, and not confident at all…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #36 · Compounds › Retatrutide · 5 Aug 2025 · 3 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
-
Travel coolers and how long they really hold Replied, post #22 · Devices › Cold chain · 1 Aug 2025 · 2 likes On travel coolers, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #3 · Compounds › Secretagogues & GH axis · 20 Jul 2025 · 17 likes Where I part company with the opening post, and it is a narrow parting. Effects reported at the level of appetite are the most consistently described and the most…
-
A field-by-field walk through a certificate of analysis Replied, post #136 · Analytics › COA interpretation · 18 Jul 2025 · 5 likes Asking for the batch record rather than the certificate is a reasonable request and the response to it is informative whichever way it goes. The evidence for this is…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #139 · Devices › Cold chain · 9 Jul 2025 · 5 likes A phase-change pack holds a defined temperature while it changes state and then behaves like anything else. A gel pack starts cold and warms continuously. They are…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #35 · Compounds › Cagrilintide & amylin analogues · 9 Jul 2025 · 0 likes Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its poor adherence was a known limitation. A weekly…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #57 · Evidence › Journal club · 28 Jun 2025 · 18 likes Practical answer on CagriSema phase 2 combination paper, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide…
-
Preparing for an appointment: one page, three questions Replied, post #24 · Clinical › Prescriber conversations · 23 Jun 2025 · 0 likes Where you have a specific worry, name it. "I am worried about X" is more useful to a clinician than a series of questions circling X. I have no interest in any supplier…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #129 · Compounds › Cagrilintide & amylin analogues · 6 Jun 2025 · 32 likes Taking post #128 at face value and following it one step further. Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #19 · Clinical › Special populations · 5 Jun 2025 · 0 likes Being outside the studied population does not mean a treatment is unsafe. It means the usual evidence is not available and the reasoning has to be explicit.
-
An emergency department visit, described afterwards Replied, post #26 · Safety › Adverse events · 31 May 2025 · 20 likes This follows post #25 rather than contradicting it. I would rather this thread reach "we do not know" about emergency department visit than reach a confident answer…
-
Antibiotics and a course of something with delayed emptying Replied, post #48 · Practice › Interactions · 24 May 2025 · 32 likes Narrowing post #45, because the general version has more than one answer. A supplement is a drug for interaction purposes, and the fact that it is sold without a…
-
A well-designed study with a badly written abstract Replied, post #65 · Evidence › Study critique · 6 May 2025 · 5 likes Where I have landed on well-designed study, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has…
-
Follow-up: What other technical communities get right that we do not Replied, post #87 · Lounge › Off topic · 4 May 2025 · 1 like That is clearer than the version I had in my head. Thank you.
-
Requesting a page: what makes a good request Replied, post #26 · Documentation › Wiki requests · 17 Mar 2025 · 7 likes Adding the measurement that post #24 says would settle it. Format suggestions: if you think a maintained page could be clearer in its presentation (different section…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #26 · Compounds › Tirzepatide · 16 Mar 2025 · 6 likes Picking up post #23: that is the part I would want checked first. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction —…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #29 · Compounds › Tirzepatide · 27 Feb 2025 · 1 like Where I part company with post #28, and it is a narrow parting. Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #3 · Evidence › Journal club · 23 Feb 2025 · 30 likes Thank you for taking the time. That was more work than a reply usually is.
-
Protein density versus volume when you cannot eat much Replied, post #101 · Nutrition & Training › Protein & intake · 9 Feb 2025 · 17 likes Answering the question post #99 raises rather than the one it answers. Where intake has fallen a long way, protein is usually the first thing to fall because it is the…
-
UK access routes, dated and sourced — a second dataset Replied, post #33 · Regional › UK & Ireland · 31 Jan 2025 · 26 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
What we do not know about retatrutide, listed explicitly Replied, post #64 · Compounds › Retatrutide · 21 Jan 2025 · 1 like Appreciated. The plain phrasing does more work here than a longer post would.
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #7 · Compounds › Repair & healing peptides · 18 Jan 2025 · 33 likes Thank you for taking the time. That was more work than a reply usually is.
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #41 · Compounds › Oral incretins · 11 Jan 2025 · 0 likes Answering the question post #39 raises rather than the one it answers. Oral semaglutide's bioavailability is low and variable, which is why the dose numbers are an…
-
[2026 update] New subcategory: rationale and scope Replied, post #137 · Meta › Announcements · 10 Jan 2025 · 31 likes The rare case here is the one that costs somebody a week, though, and the common case costs everyone ten seconds. I think the trade is clearly correct. The general case…
-
Washout with a one-week half-life: the arithmetic Replied, post #25 · Research Methods › N-of-1 designs · 27 Nov 2024 · 1 like Where I part company with post #23, and it is a narrow parting. It does not tell you about anybody else, which is why aggregating these accounts does not produce…
-
Coming back to: Reading a meta-analysis you disagree with, fairly Started this topic · Evidence › Meta-analyses · 25 Nov 2024 · 1 like Reading a meta-analysis you disagree with, fairly Writing it up because I had to work it out twice and would rather nobody else did. Reading a meta-analysis — I have…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #47 · Compounds › Tirzepatide · 21 Nov 2024 · 4 likes Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long. Practically, that means steady state is reached slightly faster and the post-dose…
-
Second pass at: Choosing a concentration on purpose rather than by accident Replied, post #17 · Practice › Reconstitution · 18 Nov 2024 · 0 likes Choosing a concentration has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #89 · Clinical › Bloodwork · 7 Oct 2024 · 0 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason. Filing this under things that are true…
-
Why I ask for the gradient before I discuss the number Replied, post #13 · Analytics › HPLC & UHPLC · 14 Aug 2024 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Guidelines revision: what changed and why Replied, post #129 · Meta › Announcements · 28 Jul 2024 · 14 likes Worth saying publicly: stepping back cleanly and handing over is a service. Documents with an absent maintainer go wrong quietly, which is the worst way for them to go…
-
The mass-error checker and its intended scope Replied, post #158 · Data & Tools › Calculators · 27 Jul 2024 · 15 likes Noted, and I have changed what I was going to do on the strength of it.
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #104 · Compounds › Retatrutide · 23 Jul 2024 · 16 likes Answering the question post #100 raises rather than the one it answers. Two things can be true about Retatrutide dose escalation at once: the mechanism is plausible and…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #88 · Compounds › Retatrutide · 22 Jul 2024 · 18 likes Retatrutide is investigational. Material obtained outside a clinical trial is research-use-only by definition, is not approved for human use, and carries no assurance…
-
Cold packs, phase-change material, and what survives ten days Replied, post #7 · Sourcing › Logistics · 11 Jun 2024 · 0 likes Everything in post #3 holds. The case it does not cover is the one I have. Photographing the parcel on arrival before opening it takes ten seconds and is the difference…